BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32483423)

  • 1. Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D
    Shang J; Zhu Z; Chen Y; Song J; Huang Y; Song K; Zhong J; Xu X; Wei J; Wang C; Cui L; Liu CY; Zhang J
    Theranostics; 2020; 10(13):5845-5864. PubMed ID: 32483423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer.
    Shang JL; Ning SB; Chen YY; Chen TX; Zhang J
    Acta Pharmacol Sin; 2021 Jan; 42(1):120-131. PubMed ID: 32541922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a cellularly active SIRT6 allosteric activator.
    Huang Z; Zhao J; Deng W; Chen Y; Shang J; Song K; Zhang L; Wang C; Lu S; Yang X; He B; Min J; Hu H; Tan M; Xu J; Zhang Q; Zhong J; Sun X; Mao Z; Lin H; Xiao M; Chin YE; Jiang H; Xu Y; Chen G; Zhang J
    Nat Chem Biol; 2018 Dec; 14(12):1118-1126. PubMed ID: 30374165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.
    Chen X; Sun W; Huang S; Zhang H; Lin G; Li H; Qiao J; Li L; Yang S
    J Med Chem; 2020 Sep; 63(18):10474-10495. PubMed ID: 32787077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin inhibited the proliferation and invasion of hepatoblastoma cells through facilitating SIRT6-medicated FZD4 silence.
    Liu T; Li Z; Tian F
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S96-S107. PubMed ID: 34219513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway.
    Dai F; Chen Y; Huang L; Wang J; Zhang T; Li J; Tong W; Liu M; Yi Z
    J Cell Mol Med; 2015 Feb; 19(2):383-95. PubMed ID: 25351103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators.
    Lu S; Chen Y; Wei J; Zhao M; Ni D; He X; Zhang J
    Acta Pharm Sin B; 2021 May; 11(5):1355-1361. PubMed ID: 34094839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Microglial Sirt6 and Inhibition of Microglial Activation by Vitamin D3 in Lipopolysaccharide-stimulated Mice and BV-2 Cells.
    Li Y; Ma Y; Gao L; Wang T; Zhuang Y; Zhang Y; Zheng L; Liu X
    Neuroscience; 2023 Aug; 526():85-96. PubMed ID: 37352968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy.
    Zhang Y; Nie L; Xu K; Fu Y; Zhong J; Gu K; Zhang L
    Theranostics; 2019; 9(8):2380-2394. PubMed ID: 31149050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of activation for the sirtuin 6 protein deacylase.
    Klein MA; Liu C; Kuznetsov VI; Feltenberger JB; Tang W; Denu JM
    J Biol Chem; 2020 Jan; 295(5):1385-1399. PubMed ID: 31822559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
    Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators.
    Klein MA; Denu JM
    J Biol Chem; 2020 Aug; 295(32):11021-11041. PubMed ID: 32518153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.
    Yang J; Li Y; Zhang Y; Fang X; Chen N; Zhou X; Wang X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):142. PubMed ID: 32711549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.